SHAYLA JEFFERSON: Open Payments
NPI 1669926564 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$804 in 36 payments from 13 companies in 2025. Trend: 2023 $171 · 2024 $843 · 2025 $804
Food & beverage: $804
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $219 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $114 |
| ABBVIE INC. | 5 | $101 |
| Exact Sciences Corporation | 3 | $75 |
| Lundbeck LLC | 4 | $74 |
| PFIZER INC. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Astellas Pharma US Inc | 1 | $32 |
| Sage Therapeutics, LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
Products named: ABILIFY MAINTENA, CAPLYTA, REXULTI, The Cologuard Plus Collection Kit, VRAYLAR, COBENFY, ABILIFY ASIMTUFII, LINZESS.
Industry payments across WI — which companies pay providers there.
